Search Result "Pulmonary arteriovenous malformations (PAVM)"
Endovascular Treatment of Pulmonary and Cerebral Arteriovenous Malformations in Patients Affected by Hereditary Haemorrhagic Teleangiectasia
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1243-1248
Author(s): E. De Cillis, N. Burdi, A. S. Bortone, D. DAgostino, T. Fiore, G. C. Ettorre, M. Resta
Is the Hepatic Factor a miRNA that Maintains the Integrity of Pulmonary Microvasculature by Inhibiting the Vascular Endothelial Growth Factor?
Journal: Current Cardiology Reviews
Volume: 13 Issue: 3 Year: 2017 Page: 244-250
Author(s): Joseph J. Vettukattil
Hereditary Haemorrhagic Teleangiectasia: Diagnostic Imaging of Visceral Involvement
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1227-1235
Author(s): Maurizio Memeo, Arnaldo Scardapane, Amato A.S. Ianora, Carlo Sabba, Giuseppe Angelelli
HHT: A Rare Disease with A Broad Spectrum of Clinical Aspects
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1217-1220
Author(s): C. Sabba, M. Gallitelli, G. Pasculli, P. Suppressa, F. Resta, E. Tafaro
Hereditary Haemorrhagic Telangiectasia (HHT): Genetic and Molecular Aspects
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1173-1193
Author(s): G. M. Lenato, G. Guanti
HHT in Childhood: Screening for Special Patients
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1221-1225
Author(s): P. Giordano, A. Nigro, G. C. Del Vecchio, C. Sabba, D. De Mattia
A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 4 Year: 2010 Page: 473-481
Author(s): Roberto Zarrabeitia, Virginia Albinana, Matilde Salcedo, B. Senaris-Gonzalez, Jose-Luis Fernandez-Forcelledo, Luisa-Maria Botella
Patients with Hereditary Hemorrhagic Telangectasia (HHT) Exhibit a Deficit of Polymorphonuclear Cell and Monocyte Oxidative Burst and Phagocytosis: A Possible Correlation with Altered Adaptive Immune Responsiveness in HHT
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1209-1215
Author(s): Anna Cirulli, Maria P. Loria, Porzia Dambra, Francesca Di Serio, Maria T. Ventura, Luigi Amati, Emilio Jirillo, Carlo Sabba
Ablation of T-Helper 1 Cell Derived Cytokines and of Monocyte-Derived Tumor Necrosis Factor-α in Hereditary Hemorrhagic Telangiectasia: Immunological Consequences and Clinical Considerations
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 1 Year: 2006 Page: 1201-1208
Author(s): F. Resta, V. Triggiani, E. Jirillo, C. Sabba, L. Amati, M. E. Passeri